|
PLEKHB2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.41770003806386E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.11129996713555E-09 |
| Normal-vs-Stage2 |
5.077200E-03 |
| Normal-vs-Stage3 |
1.66968999999462E-05 |
| Normal-vs-Stage4 |
7.68560000000695E-05 |
| Stage1-vs-Stage2 |
1.633640E-01 |
| Stage1-vs-Stage3 |
8.440600E-01 |
| Stage1-vs-Stage4 |
8.064400E-01 |
| Stage2-vs-Stage3 |
2.663600E-01 |
| Stage2-vs-Stage4 |
2.230200E-01 |
| Stage3-vs-Stage4 |
6.931200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44990000403322E-09 |
| Normal-vs-AfricanAmerican |
2.83300000014641E-07 |
| Normal-vs-Asian |
1.961990E-01 |
| Caucasian-vs-AfricanAmerican |
8.958600E-01 |
| Caucasian-vs-Asian |
5.972600E-01 |
| AfricanAmerican-vs-Asian |
6.026400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.16739995027172E-09 |
| Normal-vs-Female |
4.73329999994831E-06 |
| Male-vs-Female |
1.432360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66999999995365E-06 |
| Normal-vs-Extreme_Weight |
6.79001299630499E-12 |
| Normal-vs-Obese |
4.05059999986079E-07 |
| Normal-vs-Extreme_Obese |
8.258900E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.788400E-01 |
| Normal_Weight-vs-Obese |
5.187800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.690400E-01 |
| Extreme_Weight-vs-Obese |
1.070230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.317620E-01 |
| Obese-vs-Extreme_Obese |
6.495400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.14190000003001E-06 |
| Normal-vs-Age(41-60Yrs) |
3.41139999582296E-08 |
| Normal-vs-Age(61-80Yrs) |
3.37959999985316E-08 |
| Normal-vs-Age(81-100Yrs) |
6.22289999974157E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.196600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.038200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.385400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.557800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.572600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.283380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.57050039639728E-10 |
| Normal-VS-Type2 PRCC |
1.989500E-04 |
| Normal-VS-KIRP CIMP |
4.198100E-04 |
| Normal-VS-Unclassified PRCC |
1.585520E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.375390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.633200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.023200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.335800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.378000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.987800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12350000028394E-07 |
| Normal-vs-N1 |
2.15790000313021E-08 |
| Normal-vs-N2 |
1.520240E-02 |
| N0-vs-N1 |
5.448200E-01 |
| N0-vs-N2 |
8.139000E-01 |
| N1-vs-N2 |
5.288200E-01 |
|
|
